newsfilter
← Latest News
Business Wire·

Syros to Present at JMP Securities 2023 Life Sciences Conference

Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that its Chief Executive Officer,